Cite
Raltegravir-associated Drug-Reaction With Eosinophilia and Systemic Symptoms Syndrome in a Pediatric Patient Without Characteristic Human Leukocyte Antigen B*57:01 or B*53:01 alleles
MLA
Thomas, Sanya J., et al. “Raltegravir-Associated Drug-Reaction With Eosinophilia and Systemic Symptoms Syndrome in a Pediatric Patient Without Characteristic Human Leukocyte Antigen B*57:01 or B*53:01 Alleles.” Journal of the Pediatric Infectious Diseases Society, vol. 10, no. 3, Mar. 2021, pp. 363–66. EBSCOhost, https://doi.org/10.1093/jpids/piaa089.
APA
Thomas, S. J., Kilgore, J. T., Becken, B. A., Cunningham, C. K., & Thompson, A. B. (2021). Raltegravir-associated Drug-Reaction With Eosinophilia and Systemic Symptoms Syndrome in a Pediatric Patient Without Characteristic Human Leukocyte Antigen B*57:01 or B*53:01 alleles. Journal of the Pediatric Infectious Diseases Society, 10(3), 363–366. https://doi.org/10.1093/jpids/piaa089
Chicago
Thomas, Sanya J, Jacob T Kilgore, Bradford A Becken, Coleen K Cunningham, and Amelia B Thompson. 2021. “Raltegravir-Associated Drug-Reaction With Eosinophilia and Systemic Symptoms Syndrome in a Pediatric Patient Without Characteristic Human Leukocyte Antigen B*57:01 or B*53:01 Alleles.” Journal of the Pediatric Infectious Diseases Society 10 (3): 363–66. doi:10.1093/jpids/piaa089.